» Authors » Daniel A Ferraz

Daniel A Ferraz

Explore the profile of Daniel A Ferraz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 76
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakayama L, Ribeiro L, Goncalves M, Ferraz D, Dos Santos H, Malerbi F, et al.
Int J Retina Vitreous . 2022 Jan; 8(1):1. PMID: 34980281
Background: Artificial intelligence and automated technology were first reported more than 70 years ago and nowadays provide unprecedented diagnostic accuracy, screening capacity, risk stratification, and workflow optimization. Diabetic retinopathy is...
2.
Rentiya Z, Ferraz D, Hutnik R, Bae J, Machado C, Mucciolli C, et al.
Arq Bras Oftalmol . 2021 Sep; 85(1):37-45. PMID: 34586227
Purpose: To evaluate contrast sensitivity in non-high-risk, treatment-naïve proliferative diabetic retinopathy patients treated with panretinal photocoagulation and intravitreal injections of ranibizumab) versus panretinal photocoagulation alone. Methods: Sixty eyes of 30...
3.
Nakayama L, Goncalves M, Ferraz D, Santos H, Malerbi F, Morales P, et al.
J Diabetes Sci Technol . 2021 Jul; 15(6):1410-1411. PMID: 34259085
No abstract available.
4.
Malerbi F, Andrade R, Morales P, Stuchi J, Lencione D, de Paulo J, et al.
J Diabetes Sci Technol . 2021 Jan; 16(3):716-723. PMID: 33435711
Background: Portable retinal cameras and deep learning (DL) algorithms are novel tools adopted by diabetic retinopathy (DR) screening programs. Our objective is to evaluate the diagnostic accuracy of a DL...
5.
Motta A, Bonanomi M, Ferraz D, Preti R, Sophie R, Abalem M, et al.
Diabetes Res Clin Pract . 2019 Feb; 149:170-178. PMID: 30763599
Aims: To analyze contrast sensitivity of intravitreal bevacizumab injections with optimizing glycemic control versus optimizing glycemic control (in combination with sham injections) in eyes with Diabetic Macular Edema (DME). Design:...
6.
Preti R, Mutti A, Ferraz D, Zacharias L, Nakashima Y, Takahashi W, et al.
Clinics (Sao Paulo) . 2017 Mar; 72(2):81-86. PMID: 28273240
Objectives:: To investigate the effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on macular choroidal thickness parameters in eyes with high-risk proliferative diabetic retinopathy. Methods:: High-risk proliferative...
7.
Bittencourt M, Kherani S, Ferraz D, Ansari M, Nasir H, Sepah Y, et al.
J Ophthalmic Inflamm Infect . 2015 Nov; 4(1):14. PMID: 26530342
Background: Choroidal thickness (CTh) and choroidal vessel diameter (VD) in the Haler's layer were evaluated as markers of inflammatory insult in non-infectious uveitis (NIU). Spectral-domain optical coherence tomography (Spectralis®, Heidelberg...
8.
Ferraz D, Vasquez L, Preti R, Motta A, Sophie R, Bittencourt M, et al.
Retina . 2014 Oct; 35(2):280-7. PMID: 25272318
Purpose: To compare the efficacy of panretinal photocoagulation (PRP) and intravitreal ranibizumab injection with PRP alone in patients with treatment-naive bilateral non-high-risk proliferative diabetic retinopathy. Methods: Sixty eyes of 30...
9.
Igami T, Lavezzo M, Ferraz D, Takahashi W, Nakashima Y
Arq Bras Oftalmol . 2012 Dec; 75(4):283-5. PMID: 23258663
This case report describes the presence of bilateral macular atrophy in a patient with Alport syndrome and compares this finding with literature. At fundoscopy, there was a discrete circumscribed macular...